Document Report Card

Basic Information

ID: ALA1777757

Journal: Bioorg Med Chem Lett

Title: Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors.

Authors: Kehler J, Ritzen A, Langgård M, Petersen SL, Farah MM, Bundgaard C, Christoffersen CT, Nielsen J, Kilburn JP.

Abstract: Novel triazoloquinazolines have been found as phosphodiesterase 10A (PDE10A) inhibitors. Structure-activity studies improved the initial micromolar potency which was found in the lead compound by a 100-fold identifying 5-(1H-benzoimidazol-2-ylmethylsulfanyl)-2-methyl-[1,2,4]triazolo[1,5-c]quinazoline, 42 (PDE10A IC(50)=12 nM) as the most potent compound from the series. Two X-ray structures revealed novel binding modes to the catalytic site of the PDE10A enzyme.

CiteXplore: 21602043

DOI: 10.1016/j.bmcl.2011.04.067